P90RSK and Nrf2 activation via MEK1/2-ERK1/2 pathways mediated by notoginsenoside R2 to prevent 6-hydroxydopamine-induced apoptotic death in SH-SY5Y cells

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Meng, Xiang Bao ^a   Sun, Gui Bo ^a   Wang, Min ^a   Sun, Jing ^a   Qin, Meng ^a   Sun, Xiao Bo ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GINSENOSIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; NEUROPROTECTIVE AGENT; NOTOGINSENOSIDE R2; OXIDOPAMINE; PHOSPHATIDYLINOSITOL 3 KINASE; S6 KINASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; PANAX NOTOGINSENG; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 84885598853     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/971712     Document Type: Article

References (32)

1. Lim K. L., Zhang C. W., Molecular events underlying Parkinson's disease: an interwoven tapestry. Frontiers in Neurology 2013 4, article 33 10.3389/fneur.2013.00033
2. Trippier P. C., Jansen Labby K., Hawker D. D., Mataka J. J., Silverman R. B., Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers. Journal of Medicinal Chemistry 2013 56 8 3121 3147
3. Hwang O., Role of oxidative stress in Parkinson's disease. Experimental Neurobiology 2013 22 1 11 17
4. Yan M. H., Wang X., Zhu X., Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radical Biology and Medicine 2013 62 90 101 10.1016/j.freeradbiomed.2012.11.014
5. Lo Y.-C., Shih Y.-T., Chen I.-J., Wu Y.-C., San-Huang-Xie-Xin-Tang protects against activated microglia- and 6-OHDA-induced toxicity in neuronal SH-SY5Y cells. Evidence-Based Complementary and Alternative Medicine 2011 2011 11 2-s2.0-79952229315 10.1093/ecam/nep025 429384
6. Kumar H., Kim I. S., More S. V., Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson's disease model. Evidence-Based Complementary and Alternative Medicine 2013 2013 13 10.1155/2013/514095 514095
7. Kwon S.-H., Hong S.-I., Jung Y.-H., Kim M.-J., Kim S.-Y., Kim H.-C., Lee S.-Y., Jang C.-G., Lonicera japonica THUNB. protects 6-hydroxydopamine-induced neurotoxicity by inhibiting activation of MAPKs, PI3K/Akt, and NF- B in SH-SY5Y cells. Food and Chemical Toxicology 2012 50 3-4 797 807 2-s2.0-84856473411 10.1016/j.fct.2011.12.026
8. Luo F.-C., Wang S.-D., Qi L., Song J.-Y., Lv T., Bai J., Protective effect of panaxatriol saponins extracted from Panax notoginseng against MPTP-induced neurotoxicity in vivo. Journal of Ethnopharmacology 2011 133 2 448 453 2-s2.0-78651402013 10.1016/j.jep.2010.10.017
9. Xu L., Chen W.-F., Wong M.-S., Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF-I receptor signalling pathway. British Journal of Pharmacology 2009 158 3 738 748 2-s2.0-70350062072 10.1111/j.1476-5381.2009.00361.x
10. Kim K. H., Song K., Yoon S. H., Rescue of PINK1 protein null-specific mitochondrial complex IV deficits by ginsenoside Re activation of nitric oxide signaling. Journal of Biological Chemistry 2012 287 53 44109 44120
11. Barlow B. K., Lee D. W., Cory-Slechta D. A., Opanashuk L. A., Modulation of antioxidant defense systems by the environmental pesticide maneb in dopaminergic cells. NeuroToxicology 2005 26 1 63 75 2-s2.0-7444270637 10.1016/j.neuro.2004.07.004 (Pubitemid 39440966)
12. Du X., Xu H., Jiang H., Xie J., Akt/Nrf2 activated upregulation of heme oxygenase-1 involves in the role of Rg1 against ferrous iron-induced neurotoxicity in SK-N-SH cells. Neurotoxicity Research 2013 24 1 71 79
13. Boston S. R., Deshmukh R., Strome S., Priyakumar U. D., MacKerell A. D. Jr., Shapiro P., Characterization of ERK Docking domain inhibitors that induce apoptosis by targeting Rsk-1 and caspase-9. BMC Cancer 2011 11, article 7 2-s2.0-78650995733 10.1186/1471-2407-11-7
14. Bowser B. S., Alam S., Meyers C., Treatment of a human papillomavirus type 31b-positive cell line with benzo[a]pyrene increases viral titer through activation of the Erk1/2 signaling pathway. Journal of Virology 2011 85 10 4982 4992 2-s2.0-79955364952 10.1128/JVI.00133-11
15. Li L., Du J. K., Zou L. Y., Decursin isolated from Angelica gigas Nakai rescues PC12 cells from amyloid beta-protein-induced neurotoxicity through Nrf2-mediated upregulation of Heme oxygenase-1: potential roles of MAPK. Evidence-Based Complementary and Alternative Medicine 2013 2013 14 467245 10.1155/2013/467245
16. Sun G. B., Sun X., Wang M., Oxidative stress suppression by luteolin-induced heme oxygenase-1 expression. Toxicology and Applied Pharmacology 2012 265 2 229 240
17. Park E. J., Kim Y. M., Park S. W., Induction of HO-1 through p38 MAPK/Nrf2 signaling pathway by ethanol extract of Inula helenium L. reduces inflammation in LPS-activated RAW 264. 7 cells and CLP-induced septic mice. Food and Chemical Toxicology 2013 55 386 395
18. Xu J., Xilouri M., Bruban J., Shioi J., Shao Z., Papazoglou I., Vekrellis K., Robakis N. K., Extracellular progranulin protects cortical neurons from toxic insults by activating survival signaling. Neurobiology of Aging 2011 32 12 2326.e5 2326.e16 2-s2.0-80053643156 10.1016/j.neurobiolaging.2011.06.017
19. Zoubeidi A., Zardan A., Wiedmann R. M., Locke J., Beraldi E., Fazli L., Gleave M. E., Hsp27 promotes insulin-like growth factor-I survival signaling in prostate cancer via p90Rsk-dependent phosphorylation and inactivation of BAD. Cancer Research 2010 70 6 2307 2317 2-s2.0-77950267783 10.1158/0008-5472.CAN-09- 3252
20. Wang X., Liu J. Z., Hu J. X., Wu H., Li Y. L., Chen H. L., Bai H., Hai C. X., ROS-activated p38 MAPK/ERK-Akt cascade plays a central role in palmitic acid-stimulated hepatocyte proliferation. Free Radical Biology and Medicine 2011 51 2 539 551 2-s2.0-79959362322 10.1016/j.freeradbiomed.2011.04.019
21. Yuan Y., Jiang C. Y., Xu H., Cadmium-induced apoptosis in primary rat cerebral cortical neurons culture is mediated by a calcium signaling pathway. PLoS ONE 2013 8 5 e64330
22. Andrew R., Watson D. G., Best S. A., Midgley J. M., Wenlong H., Petty R. K. H., The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls. Neurochemical Research 1993 18 11 1175 1177 2-s2.0-0027331917 10.1007/BF00978370 (Pubitemid 23306353)
23. Chambers J. W., Howard S., LoGrasso P. V., Blocking c-Jun N-terminal kinase (JNK) translocation to the mitochondria prevents 6-hydroxydopamine- induced toxicity in vitro and in vivo. Journal of Biological Chemistry 2013 288 2 1079 1087
24. Lehmensiek V., Tan E.-M., Liebau S., Lenk T., Zettlmeisl H., Schwarz J., Storch A., Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant α -synucleins related to Parkinson's disease. Neurochemistry International 2006 48 5 329 340 2-s2.0-33644657387 10.1016/j.neuint.2005.11.008 (Pubitemid 43327272)
25. Tobon-Velasco J. C., Limon-Pacheco J. H., Orozco-Ibarra M., 6-OHDA-induced apoptosis and mitochondrial dysfunction are mediated by early modulation of intracellular signals and interaction of Nrf2 and NF-kappaB factors. Toxicology 2013 304 109 119
26. Tovilovic G., Zogovic N., Soskic V., Arylpiperazine-mediated activation of Akt protects SH-SY5Y neuroblastoma cells from 6-hydroxydopamine-induced apoptotic and autophagic death. Neuropharmacology 2013 72 224 235
27. Sriraksa N., Wattanathorn J., Muchimapura S., Tiamkao S., Brown K., Chaisiwamongkol K., Cognitive-enhancing effect of quercetin in a rat model of Parkinson's disease induced by 6-hydroxydopamine. Evidence-Based Complementary and Alternative Medicine 2012 2012 9 2-s2.0-80052689560 10.1155/2012/823206 823206
28. Cunha M. P., Martin-de-Saavedra M. D., Romero A., Protective effect of creatine against 6-hydroxydopamine-induced cell death in human neuroblastoma SH-SY5Y cells: involvement of intracellular signaling pathways. Neuroscience 2013 238 185 194
29. Kim J.-W., Li M.-H., Jang J.-H., Na H.-K., Song N.-Y., Lee C., Johnson J. A., Surh Y.-J., 15-Deoxy-Δ12,14-prostaglandin J2 rescues PC12 cells from H2O2-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2. Biochemical Pharmacology 2008 76 11 1577 1589 2-s2.0-55949091956 10.1016/j.bcp.2008.08.007
30. Yang E., Zha J., Jockel J., Boise L. H., Thompson C. B., Korsmeyer S. J., Bad, a heterodimeric partner for Bcl-x(L), and Bcl-2, displaces Bax and promotes cell death. Cell 1995 80 2 285 291 2-s2.0-0028809209
31. Bonni A., Brunet A., West A. E., Datta S. R., Takasu M. A., Greenberg M. E., Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999 286 5443 1358 1362 2-s2.0-0032698075 10.1126/science.286.5443.1358 (Pubitemid 29535895)
32. Lawrence M. C., Jivan A., Shao C., Duan L., Goad D., Zaganjor E., Osborne J., McGlynn K., Stippec S., Earnest S., Chen W., Cobb M. H., The roles of MAPKs in disease. Cell Research 2008 18 4 436 442 2-s2.0-41849088475 10.1038/cr.2008.37 (Pubitemid 351498850)